Manufacturing Facility)

Product List

Product List

Here you can find an overview of all the products that we offer in Canada.

 

Canadian regulations limit what information we are permitted to provide about our products via the Internet. Please consult a qualified health professional for more detailed information.

The Product Monograph (Product Information) and/or the Product Packaging currently available in the Canadian market might differ from the latest approved Product Monograph (Product Information) and/or Product Packaging. The latest approved versions will be made available to the Canadian market in due time.

If you have any questions or comments please contact us at CSL Behring Canada at 1-866-773-7721.

Immunology

Hizentra® | Immune Globulin Subcutaneous (Human) 20% Liquid
Product Monograph
Privigen® | Immune Globulin Intravenous (Human), 10% Liquid
Product Monograph
Cytogam® | Cytomegalovirus Immune Globulin Intravenous (Human) (CMV-IVIG) 
Product Monograph

Hematology

Humate-P® | Antihemophilic Factor/von Willebrand Factor Complex (Human)
Product Monograph
RiaSTAP™ | Fibrinogen Concentrate (Human)
Product Monograph
IDELVION™ | Coagulation Factor IX (Recombinant) Albumin Fusion Protein 
Product Monograph
AFSTYLA | Antihemophilic Factor (Recombinant) Single Chain
Product Monograph
Corifact™ | Factor XIII Concentrate (Human)
Product Monograph

Specialty Care

Berinert® 500 / Berinert® 1500 | C1-Esterase Inhibitor, Human
Product Monograph 
HAEGARDA® | C1-Esterase Inhibitor Subcutaneous, (Human)
Product Monograph
Beriplex® P/N 500 / Beriplex® P/N 1000 | Human Prothrombin Complex 
Product Monograph
Alburex® 5, Alburex® 25 | Human Albumin 
Product Monograph

The trademarks marked ® are registered by CSL Limited or its affiliates or subsidiaries in one or more jurisdictions, unless indicated otherwise.

Looking down into microscope and taking notes

Report an adverse drug reaction

If you have encountered any side effect(s) from a CSL Behring product, we encourage you to talk to your doctor, pharmacist, or nurse.

CSL Behring also collects information about adverse drug reactions in order to monitor product safety and investigate, evaluate and report adverse drug reactions to appropriate regulatory bodies.

Learn More
R&D

Innovation spans across our organization with a focus on solving patients' unmet needs.

Learn More
R&D Highlights

See what we're working on.

Learn More
Safety and manufacturing

Discover the research in progress.

Learn More